Autopsy report · NCT02737306

A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation

“Study terminated due to lack of enrolment..”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 2 months before it started.
• Ran for about 4 years 5 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 2 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

CytoDyn, Inc.

Sponsor type

Industry

Conditions

Graft Vs Host Disease

Interventions

PRO 140; Placebo

Participants

11

Sites

8

Countries

United States

Trials that died the same way

• Placebo Controlled Trial of Bosentan in Scleroderma Patients
  “Study was terminated due to inadequate enrolment” (96% match in meaning)
• Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
  “Study was terminated due to lack of accrual.” (86% match in meaning)
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
  “Study was terminated due to administrative reasons” (85% match in meaning)
• Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
  “Study has been terminated due to poor accrual.” (84% match in meaning)
• Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
  “Study terminated due to low enrollment.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.